Here are four takeaways:
1. CU Innovations collaborates with CU researchers to help bring concepts to market.
2. TranS1 will serve as an industry partner, providing concept evaluation and assisting with product development.
3. The partnership will hone in on spinal health innovation, leveraging TranS1’s research and development portfolio.
4. TranS1 believes in surgeon-led innovation, helping surgeons turn their concepts into medical devices.
More articles on devices:
Stanford University Accuro trial sees positive results: 7 insights
Zimmer Biomet, Medtronic, Integra LifeSciences & more: 17 device company notes
The Anand Spine Group 1 of 30 spine centers participating in Premia Spine’s TOPS System study — 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
